RARLIBY Trademark

Trademark Overview


On Thursday, October 29, 2020, a trademark application was filed for RARLIBY with the United States Patent and Trademark Office. The USPTO has given the RARLIBY trademark a serial number of 90287803. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2024. This trademark is owned by Gilead Sciences Ireland UC. The RARLIBY trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
rarliby

General Information


Serial Number90287803
Word MarkRARLIBY
Filing DateThursday, October 29, 2020
Status700 - REGISTERED
Status DateTuesday, October 8, 2024
Registration Number7525939
Registration DateTuesday, October 8, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events


Event DateEvent Description
Monday, November 2, 2020NEW APPLICATION ENTERED
Tuesday, December 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 29, 2021ASSIGNED TO EXAMINER
Tuesday, March 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 25, 2021SOU TEAS EXTENSION RECEIVED
Monday, October 25, 2021SOU EXTENSION 1 FILED
Monday, October 25, 2021SOU EXTENSION 1 GRANTED
Thursday, May 5, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 5, 2022SOU EXTENSION 2 FILED
Thursday, May 5, 2022SOU EXTENSION 2 GRANTED
Saturday, May 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 14, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 14, 2022SOU EXTENSION 3 FILED
Monday, November 14, 2022SOU EXTENSION 3 GRANTED
Wednesday, November 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 4, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 4, 2023SOU EXTENSION 4 FILED
Thursday, May 4, 2023SOU EXTENSION 4 GRANTED
Saturday, May 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU EXTENSION 5 FILED
Thursday, November 30, 2023SOU EXTENSION 5 GRANTED
Friday, December 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, June 12, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, June 10, 2024ASSIGNED TO PETITION STAFF
Wednesday, June 12, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, June 17, 2024NOTICE OF ALLOWANCE CANCELLED
Wednesday, July 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 8, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED